aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 3.97 USD -0.5% Market Closed
Market Cap: 333.2m USD

Wall Street
Price Targets

ATYR Price Targets Summary
aTyr Pharma Inc

Wall Street analysts forecast ATYR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATYR is 18.76 USD with a low forecast of 9.09 USD and a high forecast of 36.75 USD.

Lowest
Price Target
9.09 USD
129% Upside
Average
Price Target
18.76 USD
372% Upside
Highest
Price Target
36.75 USD
826% Upside
aTyr Pharma Inc Competitors:
Price Targets
096530
Seegene Inc
57% Upside
MAAT
Maat Pharma SA
199% Upside
SIGHT
Gensight Biologics SA
55% Upside
BBIO
BridgeBio Pharma Inc
66% Upside
KMDA
Kamada Ltd
108% Upside
CUV
Clinuvel Pharmaceuticals Ltd
129% Upside
PYC
PYC Therapeutics Ltd
185% Upside
4597
Solasia Pharma KK
34% Upside

Revenue
Forecast

Revenue Estimate
aTyr Pharma Inc

The compound annual growth rate of aTyr Pharma Inc's revenue for the next 4 years is 365%.

N/A
Past Growth
365%
Estimated Growth
Estimates Accuracy
8%
Average Beat

Operating Income
Forecast

Operating Income Estimate
aTyr Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
aTyr Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATYR's stock price target?
Price Target
18.76 USD

According to Wall Street analysts, the average 1-year price target for ATYR is 18.76 USD with a low forecast of 9.09 USD and a high forecast of 36.75 USD.

What is aTyr Pharma Inc's Revenue forecast?
Projected CAGR
365%

The compound annual growth rate of aTyr Pharma Inc's revenue for the next 4 years is 365%.

Back to Top